Victory Capital Management’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $86.5K | Sell |
17,158
-155,695
| -90% | -$785K | ﹤0.01% | 2340 |
|
|
2025
Q1 | $1.12M | Buy |
172,853
+84,077
| +95% | +$545K | ﹤0.01% | 1749 |
|
|
2024
Q4 | $652K | Buy |
88,776
+7,507
| +9% | +$55.1K | ﹤0.01% | 1956 |
|
|
2024
Q3 | $609K | Buy |
81,269
+15,696
| +24% | +$118K | ﹤0.01% | 1957 |
|
|
2024
Q2 | $584K | Buy |
65,573
+19,216
| +41% | +$171K | ﹤0.01% | 1930 |
|
|
2024
Q1 | $470K | Sell |
46,357
-28,184
| -38% | -$286K | ﹤0.01% | 2002 |
|
|
2023
Q4 | $750K | Sell |
74,541
-48,489
| -39% | -$488K | ﹤0.01% | 1842 |
|
|
2023
Q3 | $1.15M | Buy |
123,030
+18,882
| +18% | +$177K | ﹤0.01% | 1583 |
|
|
2023
Q2 | $2.55M | Buy |
104,148
+6,769
| +7% | +$166K | ﹤0.01% | 1331 |
|
|
2023
Q1 | $2.27M | Buy |
97,379
+21,736
| +29% | +$506K | ﹤0.01% | 1367 |
|
|
2022
Q4 | $1.91M | Buy |
75,643
+58,852
| +350% | +$1.49M | ﹤0.01% | 1457 |
|
|
2022
Q3 | $324K | Sell |
16,791
-2,581
| -13% | -$49.8K | ﹤0.01% | 2223 |
|
|
2022
Q2 | $493K | Sell |
19,372
-1,173
| -6% | -$29.9K | ﹤0.01% | 2059 |
|
|
2022
Q1 | $418K | Buy |
20,545
+10,073
| +96% | +$205K | ﹤0.01% | 2190 |
|
|
2021
Q4 | $438K | Buy |
10,472
+284
| +3% | +$11.9K | ﹤0.01% | 2218 |
|
|
2021
Q3 | $443K | Buy |
10,188
+1,377
| +16% | +$59.9K | ﹤0.01% | 2229 |
|
|
2021
Q2 | $417K | Buy |
8,811
+296
| +3% | +$14K | ﹤0.01% | 2293 |
|
|
2021
Q1 | $437K | Sell |
8,515
-21
| -0.2% | -$1.08K | ﹤0.01% | 2257 |
|
|
2020
Q4 | $229K | Sell |
8,536
-1,362
| -14% | -$36.5K | ﹤0.01% | 2349 |
|
|
2020
Q3 | $340K | Buy |
9,898
+977
| +11% | +$33.6K | ﹤0.01% | 2116 |
|
|
2020
Q2 | $365K | Sell |
8,921
-5,139
| -37% | -$210K | ﹤0.01% | 2097 |
|
|
2020
Q1 | $482K | Buy |
+14,060
| New | +$482K | ﹤0.01% | 2104 |
|